The American Skin Association (ASA) has announced the names of its eight 2022 award and grant recipients.
This year, Angel Byrd, MD, PhD, of the Howard University College of Medicine, and Jennifer Gill, MD, PhD, of the University of Texas Southwestern Medical Center were selected to receive the ASA Milstein Research Scholar Award for Melanoma/Non-Melanoma Skin Cancer Grants.
The recipients of the other research grants—made possible through the generosity of individuals, foundations and corporations—were also announced.
"ASA's Medical Advisory Committee is excited to announce the 2022 awards. This year's awardees indicate the growing power of research in basic, translational, and clinical Dermatology. Never before have advances in basic research so quickly led to new treatment approaches. New treatments for vitiligo, psoriasis, atopic dermatitis, melanoma and other types of skin cancer are just around the corner, fueled by important funding contributions by the ASA," said ASA president and MAC co-chair, Dr. David A. Norris.
The 2022 Investigative Scientist Award, Research Scholar Awards, Research Grants and Medical Student Grants recipients include:
2022 ASA Daneen & Charles Stiefel Investigative Scientist Award for Melanoma Research
Nicholas Gulati, MD, PhD
Icahn School of Medicine at Mount Sinai
Project Title: Use of Topical Diphencyprone to Improve Efficacy of Checkpoint Inhibition in Melanoma Patients.
2022 ASA Milstein Research Scholar Award for Melanoma/Non-Melanoma Skin Cancer
Angel Byrd, MD, PhD
Howard University College of Medicine
Project Title: Examining Gene Expression in Mycosis Fungoides in Skin of Color.
2022 ASA Milstein Research Scholar Award for Melanoma/Non-Melanoma Skin Cancer
Jennifer Gill, MD, PhD
University of Texas Southwestern Medical Center
Project Title: Characterizing the Role of GAPDHS As a Metastatic Suppressor in Human Melanoma.
2022 ASA Calder Research Scholar Award in Vitiligo/Pigment Cell Disorders
Jessica Shiu, MD, PhD
University of California Irvine
Project Title: Investigating the Role of Keratinocyte-derived Signaling Networks in Vitiligo Initiation.
2022 ASA Mulvaney Family Foundation Research Grant in Vitiligo/Pigment Cell Disorders
Ahmad Aleisa, MD, FAAD
Medical University of South Carolina
Project Title: Daily Topical Rapamycin (Sirolimus)Therapy for the Treatment of Vitiligo.
2022 ASA Castle Biosciences Research Grant for Melanoma
Goran Micevic, MD, PhD
Yale School of Medicine
Project Title: Epigenetic Regulation of Slamf6 as a Therapeutic Strategy in Melanoma Immunotherapy.
2022 ASA Medical Student Grant Targeting Melanoma and Skin Cancer
Anngela Adams
University of Arizona College of Medicine – Phoenix
Project Title: Novel Cutaneous Squamous Cell Carcinoma Model to Investigate Tumor-specific T Cell Responses.
2022 ASA Medical Student Grant Targeting Melanoma and Skin Cancer
Victoria Mroz
Icahn School of Medicine at Mount Sinai
Project Title: Role of ETS Transcription Factors in Cutaneous Squamous Cell Carcinoma Subpopulation Heterogeneity.
